Centers for Disease Control and Prevention. Vital signs: awareness and treatment of uncontrolled hypertension among adults—United States, 2003-2010. MMWR Morb Mortal Wkly Rep2012;61:703-9.
2.
WilkinsKCampbellNRJoffresMR. Blood pressure in Canadian adults. Health Rep2010;21:37-46.
3.
JamesPAOparilSCarterBL. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA2014;311:507-20.
4.
EganBMZhaoYAxonRN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA2010;303:2043-50.
5.
JoffresMFalaschettiEGillespieC. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open2013;3:e003423.
6.
DobsonRTTaylorJGHenryCJ. Taking the lead: community pharmacists’ perception of their role potential within the primary care team. Res Social Adm Pharm2009;5:327-36.
7.
CarterBLBosworthHBGreenBB. The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy. J Clin Hypertens2012;14:51-65.
8.
Chisholm-BurnsMAKim LeeJSpiveyCA. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Medical Care2010;48:923-33.
9.
HouleSKChatterleyTTsuyukiRT. Multidisciplinary approaches to the management of high blood pressure. Curr Opin Cardiol2014;29:344-53.
10.
McAlisterFAMajumdarSRPadwalRS. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. CMAJ2014;186:577-84.
11.
McLeanDLMcAlisterFAJohnsonJA. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: Study of Cardiovascular Risk Intervention by Pharmacists—Hypertension (SCRIP-HTN). Arch Intern Med2008;168:2355-61.
12.
SantschiVChioleroABurnandB. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med2011;171:1441-53.
13.
TsuyukiRTJohnsonJATeoKK. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med2002;162:1149-1155.
14.
SantschiVChioleroAColosimoAL. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc2014;3:e000718.
15.
LawMRMorrisJKWaldNJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ2009;338:b1665.
16.
Community Preventive Services Task Force. Team-based care to improve blood pressure control: recommendation of the community preventive services task force. Am J Prev Med2014;47:100-2.
17.
ProiaKKThotaABNjieGJ., Community Preventive Services Task Force. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med2014;47:86-99.
18.
CampbellNRPoirierLTremblayG., Canadian Hypertension Education Panel. Canadian Hypertension Education Program: the science supporting new 2011 CHEP recommendations with an emphasis on health advocacy and knowledge translation. Can J Cardiol2011;27:407-14.
19.
ManciaGFagardRNarkiewiczK. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J2013;34:2159-219.
